Use Central Contact
Astellas Pharma Inc · Astellas Pharma Europe B.V. · Astellas Pharma Europe Ltd.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Use Central Contact as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:43 UTC. Open this list on ClinicalTrials.gov
- N/ANCT02160054 · Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)Astellas Pharma Inc · completed · the Maintenance Phase After Kidney Transplantation · study director
- N/ANCT02087098 · A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other AntimuscarinicsAstellas Pharma Europe B.V. · completed · Urinary Bladder, Overactive · study director
- N/ANCT01903213 · Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal DialysisAstellas Pharma Inc · completed · Chronic Renal Failure · study director
- N/ANCT01901107 · Post-marketing Surveillance of Kiklin Capsules in Hemodialysis PatientsAstellas Pharma Inc · completed · Chronic Renal Failure Patients With Hyperphosphataemia Receiving Hemodialysis · study director
- N/ANCT01887613 · Specified Drug Use-Results Survey of RegniteAstellas Pharma Inc · completed · Restless Legs Syndrome · study chair
- N/ANCT01876121 · Celecoxib Japan Observational Study for the Patients With Acute PainAstellas Pharma Inc · completed · Patients With Traumatic Pain, Post-surgical Pain and Tooth Extract Pain · study chair
- N/ANCT01870908 · Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis PatientsAstellas Pharma Inc · completed · Rheumatoid Arthritis · study director
- Ph1NCT01674777 · A Study to Investigate the Effect of Food on the Absorption, Distribution and Elimination of ASP1941Astellas Pharma Inc · completed · Healthy, Pharmacokinetics of ASP1941 · study chair
- Ph1NCT01514825 · A Study to Investigate the Plasma Concentration of YM150 After Repeated Administration to Elderly SubjectsAstellas Pharma Inc · completed · Healthy Elderly Subject, Pharmacokinetic of YM150 · study chair
- Ph1NCT01514812 · A Study to Investigate the Effect of YM150 on the Plasma Concentration of Digoxin in Healthy SubjectsAstellas Pharma Inc · completed · Healthy, Pharmacokinetic of Digoxin · study chair
- Ph3NCT01514838 · A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes MellitusAstellas Pharma Inc · terminated · Type II Diabetes Mellitus · study chair
- Ph4NCT01511003 · A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)Astellas Pharma Inc · completed · Rheumatoid Arthritis · study chair
- Ph3NCT01505426 · A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes PatientsAstellas Pharma Inc · completed · Type II Diabetes Mellitus · study chair
- N/ANCT01489709 · Post Marketing Survey of Vesicare in JapanAstellas Pharma Inc · completed · Overactive Bladder · study chair
- Ph2NCT01450579 · A Study to Evaluate the Immune Response to the ASP7373 and Its Safety in Healthy Adult VolunteersUMN Pharma Inc. · completed · Healthy · study chair
- Ph1NCT01423435 · Study to Compare Pharmacokinetic Profiles of TRK-100STP in Japanese, Chinese, and South Korean Non-elderly Healthy Adult MalesAstellas Pharma Inc · completed · Healthy Adult Male, Pharmacokinetics of TRK-100-STP · study chair
- N/ANCT01410747 · A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use SituationsAstellas Pharma Inc · completed · Lupus Nephritis · study chair
- Ph1NCT01403818 · A Study to Assess the Effect of ASP1941 and Mitiglinide on Their Plasma ConcentrationAstellas Pharma Inc · completed · Healthy, Pharmacokinetics of ASP1941, Pharmacokinetics of Mitiglinide · study chair
- Ph1NCT01401504 · Study of an Investigational Drug, ASP3026, in Patients With Solid TumorsAstellas Pharma Inc · completed · Solid Tumor · study chair
- Ph1/Ph2NCT01393951 · A Study to Evaluate the Immune Response to the ASP7374 and Its Safety in Healthy Adult VolunteersUMN Pharma Inc. · completed · Healthy, Immunogenicity of ASP7374 · study chair
- Ph1NCT01394653 · A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet and Conventional Tablet Under With Water IntakeAstellas Pharma Inc · completed · Healthy, Plasma Concentration of YM060 · study chair
- Ph1NCT01392794 · A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet (Without Water) and Conventional TabletAstellas Pharma Inc · completed · Healthy, Plasma Concentration of YM060 · study chair
- Ph1NCT01373060 · A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of ASP1941 in Healthy Male Taiwanese SubjectsAstellas Pharma Inc · completed · Healthy, Pharmacokinetics of ASP1941 · study chair
- Ph4NCT01363752 · A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.Astellas Pharma Inc · completed · Kidney Transplantation · study director
- Ph1/Ph2NCT01352208 · Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) PatientsAstellas Pharma Inc · terminated · Castrate Resistant Prostate Cancer · study director
- Ph3NCT01342016 · A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis PatientsAstellas Pharma Inc · terminated · Lupus Nephritis · study chair
- Ph4NCT01339468 · A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver TransplantationAstellas Pharma Inc · completed · Liver Transplantation · study chair
- Ph1NCT01334905 · A Study to Investigate the Safety and Effect of Food on the Pharmacokinetics of YM178 in Healthy VolunteersAstellas Pharma Inc · completed · Healthy Volunteer, Pharmacokinetics of YM178 · study chair
- Ph2NCT01332201 · Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®Astellas Pharma Inc · completed · Heart Transplantation, Lung Transplantation, Pancreas (Including SPK) Transplantation · study chair
- Ph3NCT01325571 · A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia GravisAstellas Pharma Inc · completed · Myasthenia Gravis · study chair
- Ph4NCT01318837 · A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin TreatmentAstellas Pharma Inc · completed · Over Active Bladder · principal investigator
- N/ANCT01317810 · A Study Measuring and Tracking Changes in Overactive Bladder (OAB) MedicationAstellas Pharma Inc · withdrawn · Overactive Bladder (OAB) · study director
- Ph4NCT01316133 · A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis PatientsAstellas Pharma Korea, Inc. · terminated · Lupus Nephritis · study chair
- Ph4NCT01304836 · A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without SteroidsAstellas Pharma Inc · completed · Kidney Transplantation · study director
- Ph1NCT01302028 · Renal Impairment Study With ASP1941Astellas Pharma Inc · completed · Type 2 Diabetes Mellitus · study director
- Ph1NCT01302158 · Drug-drug Interaction Study With ASP1941 and GlimepirideAstellas Pharma Inc · completed · Healthy Subjects · study director
- Ph1NCT01302145 · Drug to Drug Interaction Study With ASP1941 and MetforminAstellas Pharma Inc · completed · Type 2 Diabetes Mellitus · study director
- Ph1NCT01302132 · Mass Balance Study of ASP1941Astellas Pharma Inc · completed · Healthy Subjects · study director
- Ph2NCT01302041 · A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone TherapyAstellas Pharma Inc · completed · Prostate Cancer · study director
- Ph1NCT01297179 · A Study to Evaluate the Possible Effects of Taking Mirabegron While Taking a Contraceptive PillAstellas Pharma Inc · completed · Healthy Volunteers, Pharmacokinetics of Mirabegron · study director
- Ph1NCT01297192 · A Clinical Study to Assess the Effect on Pharmacokinetics of Dosing Mirabegron (YM178) and Solifenacin SimultaneouslyAstellas Pharma Inc · completed · Healthy Volunteers, Pharmacokinetics of Mirabegron · study director
- Ph2NCT01294020 · Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®Astellas Pharma Europe Ltd. · completed · Intestine Transplantation, Kidney Transplantation, Lung Transplantation · study chair
- Ph1NCT01288885 · First in Men Study of Single Oral Doses of ASP1941 in Healthy SubjectsAstellas Pharma Inc · completed · Healthy · study director
- Ph1NCT01288898 · Multiple Dose Escalating Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1941Astellas Pharma Inc · completed · Healthy · study director
- Ph1NCT01285596 · A Study to Evaluate How Mirabegron Enters and Leaves the Bloodstream According to Age and SexAstellas Pharma Inc · completed · Healthy Volunteers, Pharmacokinetics of Mirabegron · study director
- Ph1NCT01284868 · A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron.Astellas Pharma Inc · completed · Healthy Volunteers, Pharmacodynamics of Mirabegron · study director
- Ph1/Ph2NCT01284920 · A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer PatientsAstellas Pharma Inc · completed · Prostate Cancer, Prostate Neoplasms, Castration Resistant Prostate Cancer (CRPC) · study chair
- Ph1NCT01279915 · A Safety and Pharmacokinetics Study of ASP0456 in Healthy SubjectsAstellas Pharma Inc · completed · Healthy, Pharmacokinetics of ASP0456 · study chair
- Ph2NCT01274000 · A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female PatientsAstellas Pharma Inc · completed · Irritable Bowel Syndrome · study chair
- Ph1NCT01262391 · Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and AdolescentsAstellas Pharma Inc · completed · Urinary Bladder, Overactive · study chair
- Ph2NCT01261572 · Study to Find Maintenance Dose for Periodic Administration of ASP3550Astellas Pharma Inc · completed · Prostatic Neoplasms · study chair
- Ph4NCT01252160 · Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve DamageAstellas Pharma Inc · completed · Neuralgia, Postherpetic · study chair
- Ph3NCT01242215 · A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic PatientsAstellas Pharma Inc · completed · Type 2 Diabetes Mellitus · study chair
- Ph3NCT01242228 · A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic PatientsAstellas Pharma Inc · completed · Type 2 Diabetes Mellitus · study chair
- Ph3NCT01242202 · A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic PatientsAstellas Pharma Inc · completed · Type 2 Diabetes Mellitus · study chair
- Ph1NCT01232413 · A Study of the Effect of ASP1941 on Cardiac Repolarization in Healthy SubjectsAstellas Pharma Inc · completed · Healthy Subjects, Cardiac Repolarization · study director
- Ph4NCT01224418 · A Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to MethotrexateAstellas Pharma Inc · completed · Rheumatoid Arthritis · study chair
- Ph1NCT01225224 · Single and Multiple Oral Administration Study of ASP015K in Healthy Nonelderly VolunteersAstellas Pharma Inc · completed · Pharmacokinetics of ASP015K, Healthy Volunteer · study chair
- Ph3NCT01225081 · A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic PatientsAstellas Pharma Inc · completed · Type 2 Diabetes Mellitus · study chair
- Ph4NCT01225237 · A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male PatientsAstellas Pharma Inc · completed · Irritable Bowel Syndrome · study chair
- Ph4NCT01224041 · Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to MethotrexateAstellas Pharma Inc · completed · Rheumatoid Arthritis · study chair
- Ph2NCT01224028 · A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy PatientsAstellas Pharma Inc · completed · IgA Nephropathy · study chair
- Ph1NCT01199523 · A Study to Evaluate the Effect of Oral Mirabegron on the Heart in Healthy Males and FemalesAstellas Pharma Inc · completed · Healthy Subjects · study director
- Ph1NCT01190670 · A Study to Evaluate the Drug Interaction of ASP015K and TacrolimusAstellas Pharma Inc · completed · Healthy, Pharmacokinetics of ASP015K and Tacrolimus · study director
- Ph1NCT01187186 · A Study to Assess the Effect of Hepatic Function on the Pharmacokinetics and Safety of ASP1941Astellas Pharma Inc · completed · Liver Disease · study director
- Ph1NCT01182077 · A Study to Assess Drug Interaction of ASP015K and MidazolamAstellas Pharma Inc · completed · Healthy, Pharmacokinetics of ASP015K and Midazolam · study director
- Ph4NCT01181232 · A Study to Compare Efficacy and Safety of Zolpidem Modified Release Formulation Versus Zolpidem in Insomnia PatientsAstellas Pharma Inc · completed · Sleep Initiation and Maintenance Disorders, Primary Insomnia · study chair
- Ph4NCT01135589 · Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell TransplantationAsan Medical Center · unknown · Neutropenia, Hematopoietic Stem Cell Transplantation, Invasive Fungal Disease · study chair
- Ph3NCT01135433 · A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic PatientsAstellas Pharma Inc · completed · Type 2 Diabetes Mellitus · study chair
- Ph4NCT01126424 · A Study to Compare Two Medications With an Inactive Medication and Look at the Effect on a Person's Mental AbilityAstellas Pharma Inc · completed · Cognition · study director
- Ph1NCT01125670 · A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150 TabletAstellas Pharma Inc · completed · Healthy Volunteer, Pharmacokinetics of YM150 · study chair
- Ph1NCT01125657 · A Study to Compare the Pharmacokinetics of YM150 Formulation-A and Formulation-BAstellas Pharma Inc · completed · Healthy Volunteer, Pharmacokinetics of YM150 · study chair
- Ph1NCT01124747 · A Study to Assess the Systemic Disposition of ASP1585 After Administration of 14C-labeled DrugAstellas Pharma Inc · completed · Healthy, Pharmacokinetics of ASP1585 · study director
- N/ANCT01122550 · Reproducibility Study of Overactive Bladder Symptom Score [OABSS]Astellas Pharma Inc · completed · Overactive Bladder · study chair
- N/ANCT01122563 · A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to TreatmentAstellas Pharma Inc · completed · Overactive Bladder · study chair
- Ph2NCT01122368 · A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical SubjectsAstellas Pharma Inc · completed · Mycoses · study chair
- Ph1NCT01121198 · A Study to Assess Safety and Tolerability of ASP1941 After Single and Repeated Administration in Healthy SubjectsAstellas Pharma Inc · completed · Healthy Volunteer, Pharmacokinetics of ASP1941 · study chair
- Ph3NCT01118572 · A Study to Verify the Efficacy of YM177 (Celecoxib) in Postoperative Pain PatientsAstellas Pharma Inc · completed · Post Operative Pain · study chair
- Ph1NCT01118559 · A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150Astellas Pharma Inc · completed · Healthy, Pharmacokinetics of YM150 · study chair
- Ph1NCT01115985 · A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Atorvastatin in Healthy VolunteersAstellas Pharma Inc · completed · Healthy, Pharmacokinetics of Atorvastatin · study chair
- Ph1NCT01115946 · A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Enalapril in Healthy VolunteersAstellas Pharma Inc · completed · Healthy, Pharmacokinetics of Enalapril · study chair
- Ph1NCT01115972 · A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Valsartan in Healthy VolunteersAstellas Pharma Inc · completed · Healthy, Pharmacokinetics of Valsartan · study chair
- Ph1NCT01104532 · A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Sitagliptin When Given Together to Healthy SubjectsAstellas Pharma Inc · completed · Healthy, Pharmacokinetics of ASP1941 · study director
- Ph1NCT01099839 · A Study to Assess Drug-Drug Interaction Between ASP1941 and MiglitolAstellas Pharma Inc · completed · Healthy Volunteers, Pharmacokinetics of ASP1941 · study chair
- Ph1NCT01097681 · A Study to Assess the Pharmacokinetics, Pharmacodynamics of ASP1941 in Diabetes Mellitus Patients With Renal ImpairmentAstellas Pharma Inc · completed · Type 2 Diabetes Mellitus · study chair
- Ph4NCT01093534 · Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.Astellas Pharma Inc · completed · Detrusor Overactivity, Overactive Bladder · study chair
- Ph1NCT01088919 · A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Pioglitazone Hydrochloride When Given Together to Healthy SubjectsAstellas Pharma Inc · completed · Healthy, Pharmacokinetics of ASP1941 · study director
- Ph1NCT01083888 · ASP1517 Pharmacokinetics Study in Anemia Patients on HemodialysisAstellas Pharma Inc · completed · Anemia, Hemodialysis, Renal Impairment · study chair
- Ph3NCT01058174 · Liver Transplant European Study Into the Prevention of Fungal InfectionAstellas Pharma Inc · completed · Liver Transplantation, Mycoses · study director
- Ph3NCT01057407 · A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on HemodialysisAstellas Pharma Inc · completed · Chronic Kidney Disease, Renal Dialysis, Renal Insufficiency · study chair
- Ph3NCT01057628 · A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes PatientsAstellas Pharma Inc · completed · Type 2 Diabetes Mellitus · study chair
- Ph3NCT01054092 · A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic PatientsAstellas Pharma Inc · completed · Type 2 Diabetes Mellitus · study chair
- Ph3NCT01043666 · A Study of YM178 in Subjects With Symptoms of Overactive BladderAstellas Pharma Inc · completed · Urinary Bladder, Overactive · study chair
- Ph3NCT01028950 · YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical IllnessAstellas Pharma Inc · completed · Venous Thromboembolism · study chair
- N/ANCT01029015 · Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal SubjectsAstellas Pharma Inc · completed · Bladder Function · principal investigator
- Ph1NCT01023945 · A Study of ASP1941 in Japanese Patients With Type 2 Diabetes MellitusAstellas Pharma Inc · completed · Type 2 Diabetes Mellitus · study chair
- Ph1NCT01023386 · A Clinical Pharmacological Study of YM155 After Intravenous Infusion in Patients With Advanced CancerAstellas Pharma Inc · completed · Cancer · study chair
- Ph3NCT01021332 · Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract SymptomsAstellas Pharma Europe B.V. · completed · Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia · study chair
- Ph4NCT01018914 · A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation PatientsAstellas Pharma Inc · completed · Liver Transplantation · study chair
- Ph3NCT01018511 · Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract SymptomsAstellas Pharma Europe B.V. · completed · Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms · study chair
- Ph3NCT01017276 · A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal DialysisAstellas Pharma Inc · completed · Chronic Kidney Disease, Renal Dialysis, Renal Insufficiency · study chair
- Ph1NCT01016054 · A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian CancerAstellas Pharma Inc · terminated · Carcinoma, Ovarian Cancer, Ovarian Diseases · study director
- Ph1NCT01015040 · Relative Bioavailability Study of Solifenacin Succinate Liquid Suspension (Fed and Fasting) Versus VESIcare Tablet (Fasting) in Healthy VolunteersAstellas Pharma Inc · completed · Bioavailability of Solifenacin Succinate, Pharmacokinetics of Solifenacin Succinate, Healthy Volunteers · study director
- Ph3NCT01011205 · Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver TransplantationAstellas Pharma Inc · completed · Liver Transplantation · study chair
- Ph3NCT00999219 · A Study of FK199B to Compare Efficacy With Zolpidem by Polysomnography in Patients With InsomniaAstellas Pharma Inc · completed · Sleep Initiation and Maintenance Disorders · study chair
- Ph2NCT00994292 · Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary SyndromesAstellas Pharma Europe B.V. · completed · Acute Coronary Syndrome · study director
- N/ANCT00985387 · Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder PatientsAstellas Pharma Inc · completed · Urinary Bladder, Overactive, Overactive Bladder · study chair
- Ph1NCT00978198 · Safety, Tolerability and Pharmacokinetic Study of ASP1517 in Healthy Non-elderly Male VolunteersAstellas Pharma Inc · completed · Healthy Volunteers · study chair
- Ph1NCT00965926 · A Study to Investigate the Food Effect on the Pharmacokinetics of YM178 in Healthy, Non-elderly VolunteersAstellas Pharma Inc · completed · Healthy Volunteer, Pharmacokinetics of YM178 · study chair
- Ph3NCT00966004 · A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive BladderAstellas Pharma Inc · completed · Urinary Bladder, Overactive · study chair
- Ph1NCT00965978 · A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent FormulationAstellas Pharma Inc · completed · Osteoporosis, Osteoporosis, Postmenopausal, Bone Diseases · study chair
- Ph4NCT00956319 · A Study to Evaluate Efficacy and Safety of Zolpidem Modified Release Formulation in Insomnia PatientsAstellas Pharma Inc · completed · Sleep Initiation and Maintenance Disorders, Primary Insomnia · study chair
- Ph3NCT00942435 · A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal SurgeryAstellas Pharma Inc · completed · Venous Thromboembolism · study chair
- Ph1NCT00940121 · Pharmacokinetics of Oral Mirabegron With Different Release Rates Versus Intravenous (IV) MirabegronAstellas Pharma Inc · completed · Healthy, Pharmacokinetics of Mirabegron · study director
- Ph1NCT00939757 · Study of the Effect of Food on the Pharmacokinetics of MirabegronAstellas Pharma Inc · completed · Healthy, Pharmacokinetics of Mirabegron · study director
- Ph2NCT00938730 · A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial FibrillationAstellas Pharma Inc · completed · Atrial Fibrillation · study chair
- Ph3NCT00937911 · Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower ExtremitiesAstellas Pharma Inc · completed · Venous Thromboembolism · study chair
- Ph3NCT00937820 · Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous ThromboembolismAstellas Pharma Inc · completed · Venous Thromboembolism · study chair
- Ph3NCT00933231 · Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal AllograftsAstellas Pharma Inc · completed · Kidney Transplantation · study director
- Ph1NCT00920998 · Effect of Food Intake on Pharmacokinetic Profiles of Z-338Astellas Pharma Inc · completed · Healthy · study chair
- Ph4NCT00918411 · A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel SyndromeAstellas Pharma Inc · completed · Irritable Bowel Syndrome · study chair
- Ph2/Ph3NCT00917254 · Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement SurgeryAstellas Pharma Inc · completed · Venous Thromboembolism · study chair
- Ph2/Ph3NCT00913120 · Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement SurgeryAstellas Pharma Inc · completed · Venous Thromboembolism · study chair
- Ph3NCT00912964 · A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive BladderAstellas Pharma Inc · completed · Urinary Bladder, Overactive · study director
- Ph3NCT00909571 · Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release TacrolimusAstellas Pharma Inc · completed · Liver Transplantation · study chair
- N/ANCT00902980 · Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community ClinicsAstellas Pharma Inc · completed · Kidney Transplantation · study director
- Ph2/Ph3NCT00902928 · A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement SurgeryAstellas Pharma Europe B.V. · completed · Venous Thromboembolism, Arthroplasty, Replacement, Hip · study chair
- N/ANCT00901251 · Reproducibility Study of Over Active Bladder Symptom Score [OABSS]Astellas Pharma Inc · completed · Overactive Bladder · study chair
- Ph3NCT00892749 · Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on HemodialysisAstellas Pharma Inc · completed · Chronic Kidney Disease, Renal Dialysis, Renal Insufficiency · study chair
- Ph4NCT00885820 · Benefit of Early Protocol Biopsy and Treatment of Subclinical RejectionAstellas Pharma Inc · completed · Kidney Transplantation · study director
- Ph1NCT00870441 · Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy VolunteersAstellas Pharma Inc · terminated · Safety of ASP2151 · study director
- Ph4NCT00862641 · A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary DiseaseAstellas Pharma Inc · completed · Asthma, Coronary Artery Disease, Pulmonary Disease, Chronic Obstructive · study director
- Ph1NCT00856570 · A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy SubjectsAstellas Pharma Inc · completed · Overactive Bladder, Pharmacokinetics · study chair
- Ph1NCT00850746 · A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy AdultsAstellas Pharma Inc · completed · Functional Dyspepsia · study director
- Ph3NCT00840645 · A Long-term Study of YM178 in Symptomatic Overactive Bladder PatientsAstellas Pharma Inc · completed · Urinary Bladder, Overactive · study chair
- Ph3NCT00826280 · Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)Astellas Pharma Inc · completed · Coronary Artery Disease (CAD) · study director
- Ph1NCT00818584 · An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in NeonatesAstellas Pharma Inc · completed · Candida · study director
- Ph1NCT00818194 · Comparison of Extended Release Tacrolimus (Advagraf) and Cyclosporine A Microemulsion on Renal Function in Healthy VolunteersAstellas Pharma Inc · completed · Healthy · study director
- Ph1NCT00816764 · A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian CancerAstellas Pharma Inc · completed · Carcinoma, Ovarian Cancer, Ovarian Diseases · study director
- Ph1NCT00816686 · A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell CancerAstellas Pharma Inc · terminated · Carcinoma, Renal Cell, Kidney Neoplasms, Kidney Diseases · study director
- N/ANCT00811876 · Retrospective, Non-interventional Study of Depo-Eligard®.Astellas Pharma Inc · completed · Prostate Cancer · study director
- N/ANCT00795353 · Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque PsoriasisAstellas Pharma Inc · terminated · Chronic Plaque Psoriasis · study director
- Ph3NCT00794703 · A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal InfectionsAstellas Pharma Inc · completed · Fungemia, Fungal Infections · study chair
- Ph2NCT00790660 · A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.Astellas Pharma Inc · completed · Diabetes Mellitus, Type 2 · study director
- Ph3NCT00674063 · A Study to Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque PsoriasisAstellas Pharma Inc · completed · Chronic Plaque Psoriasis · study director
- Ph3NCT00673556 · A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or InappropriateAstellas Pharma Inc · completed · Chronic Plaque Psoriasis · study director
- Ph4NCT00673725 · Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic DermatitisAstellas Pharma Europe B.V. · completed · Dermatitis, Atopic · study chair
- Ph2NCT00668070 · A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831Astellas Pharma Inc · completed · Non-Alcoholic Steatohepatitis · study chair
- Ph4NCT00667056 · Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact DermatitisAstellas Pharma Inc · completed · Dermatitis · study director
- Ph4NCT00667160 · Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic DermatitisAstellas Pharma Inc · completed · Dermatitis, Atopic · study director
- Ph4NCT00666159 · Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic DermatitisAstellas Pharma Inc · completed · Dermatitis, Atopic · study director
- Ph3NCT00665639 · Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal CandidiasisAstellas Pharma Inc · completed · Candidiasis, Oral · study director
- Ph4NCT00666302 · A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic DermatitisAstellas Pharma Inc · completed · Dermatitis, Atopic · study director
- Ph3NCT00666185 · Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal CandidiasisAstellas Pharma Inc · completed · Candidiasis, Oral · study director
- Ph3NCT00662909 · A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive BladderAstellas Pharma Inc · completed · Urinary Bladder, Overactive · study director
- Ph2NCT00659412 · A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic ArthritisAstellas Pharma Inc · completed · Psoriatic Arthritis · study director
- Ph4NCT00658606 · Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis SubjectsAstellas Pharma Inc · completed · Plaque Psoriasis · study director
- Ph1NCT00653822 · A Study of Pharmacokinetics and Safety of Alefacept in Caucasian and Japanese Healthy VolunteersAstellas Pharma Inc · completed · Pharmacokinetics of Alefacept · study director
- Ph4NCT00653562 · Zolpidem (Myslee) Post Marketing Study in Adolescent Patients With Insomnia - Evaluation With PolysomnographyAstellas Pharma Inc · completed · Insomnia, Sleep Initiation and Maintenance Disorders · study chair
- Ph3NCT00643071 · Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis PatientsAstellas Pharma Inc · completed · Ulcerative Colitis · study chair
- Ph2NCT00507455 · Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet ObstructionAstellas Pharma Inc · completed · Lower Urinary Tract Symptoms, Bladder Outlet Obstruction · study director
- Ph2NCT00505037 · A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on HemodialysisAstellas Pharma Inc · completed · Hyperphosphatemia, Chronic Kidney Disease · study chair
- Ph2NCT00498914 · Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) SubjectsAstellas Pharma Inc · terminated · Lymphoma, Large-Cell, Diffuse, Lymphoma, B-Cell Refractory · study director
- Ph4NCT00493324 · Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque PsoriasisAstellas Pharma Inc · completed · Chronic Plaque Psoriasis · study director
- Ph2NCT00487682 · Dose-finding Study of ASP2151 in Subjects With Herpes ZosterAstellas Pharma Inc · completed · Herpes Zoster · study chair
- Ph2NCT00486200 · A Study With ASP2151 in Subjects With Recurrent Episodes of Genital HerpesAstellas Pharma Inc · completed · Herpes Genitalis · study director
- Ph3NCT00480896 · Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus OintmentAstellas Pharma Inc · completed · Dermatitis, Atopic · principal investigator
- Ph3NCT00480610 · Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus OintmentAstellas Pharma Inc · completed · Dermatitis, Atopic · principal investigator
- Ph3NCT00463541 · Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder SymptomsAstellas Pharma Inc · completed · Urinary Bladder, Overactive · study director
- Ph3NCT00454896 · A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB)Astellas Pharma Inc · completed · Urinary Bladder, Overactive · study director
- Ph3NCT00454740 · Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive BladderAstellas Pharma Inc · completed · Urinary Bladder, Overactive · study director
- Ph2NCT00454233 · A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus SubjectsAstellas Pharma Inc · completed · Diabetes Mellitus Type 2 · study chair
- Ph2NCT00451932 · A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant PatientsAstellas Pharma Inc · completed · Liver Transplantation · principal investigator
- Ph4NCT00432198 · Zolpidem Postmarketing Study in Adolescent Patients With InsomniaAstellas Pharma Inc · completed · Insomnia · study chair
- Ph4NCT00431041 · Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR)Astellas Pharma Inc · completed · Overactive Bladder · study director
- Ph3NCT00429377 · Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative StudyAstellas Pharma Inc · completed · Lupus Nephritis · study director
- Ph4NCT00423163 · A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive AspergillosisAstellas Pharma Inc · withdrawn · Aspergillosis/Blood, Aspergillosis/Invasive · study director
- Ph1/Ph2NCT00411424 · Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid ArthritisAstellas Pharma Inc · completed · Rheumatoid Arthritis · study director
- Ph2NCT00410514 · A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)Astellas Pharma Inc · completed · Lower Urinary Tract Symptoms, Bladder Outlet Obstruction · study director
- Ph4NCT00408382 · Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary PlaqueAstellas Pharma Inc · completed · Hypercholesteremia, Coronary Artery Disease · study director
- Ph3NCT00384137 · A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney RecipientsAstellas Pharma Inc · completed · Transplantation · study director
- Ph3NCT00384202 · A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver RecipientsAstellas Pharma Inc · completed · Transplantation · study director
- Ph4NCT00379067 · A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.Astellas Pharma Inc · completed · Benign Prostatic Hyperplasia · study director
- Ph3NCT00374777 · A Double-blind, Group-comparison P-III Study With Zolpidem MR Using Placebo and Nitrazepam in Insomnia PatientsAstellas Pharma Inc · completed · Sleep Initiation and Maintenance Disorders · study chair
- N/ANCT00371774 · Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.E™) ProgramAstellas Pharma Inc · completed · Plaque Psoriasis · study director
- Ph3NCT00368706 · A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder PatientsAstellas Pharma Inc · completed · Urinary Bladder, Overactive · principal investigator
- Ph3NCT00347048 · Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis PatientsAstellas Pharma Inc · completed · Ulcerative Colitis · study chair
- Ph3NCT00281554 · Study of RSD1235 to Evaluate Safety in Patients With Atrial FibrillationAstellas Pharma Inc · completed · Atrial Fibrillation · study director
- Ph3NCT00272285 · A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and NauseaAstellas Pharma Inc · completed · Vomiting, Nausea · study chair
- Ph3NCT00115791 · Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial FlutterAstellas Pharma Inc · completed · Atrial Flutter, Atrial Fibrillation · study director
- Ph4NCT00106496 · A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic DermatitisAstellas Pharma Inc · completed · Dermatitis, Atopic · study director
- Ph3NCT00106288 · Micafungin Versus AmBisome in Invasive Candidiasis and CandidemiaAstellas Pharma Inc · completed · Candidiasis · study chair
- Ph2NCT00087724 · A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's DiseaseAstellas Pharma Inc · terminated · Alzheimer's Disease · study director
- Ph3NCT00064701 · Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant RecipientsAstellas Pharma Inc · completed · Kidney Transplantation · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:43 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:43 UTC. The ranking covers the 200 most relevant of 1 PubMed records, and a shared surname and initials can bring in a namesake. All 1 on PubMed
- 85 citationsRCR 3.7